文献速递肺外科

增强现实导航引导肺结节定位系统的前瞻性多中心单臂研究

A Prospective, Multicenter, Single-Arm Study to Evaluate the Efficacy and Safety of Augmented Reality Navigation-Guided Pulmonary Nodule Localization System.
PubMed 文献 · Eur J Cardiothorac Surg · 2026-01-01

该前瞻性多中心单臂研究评估增强现实导航引导肺结节定位系统在亚厘米肺结节术前定位中的有效性与安全性。共106例患者接受定位后行电视辅助胸腔镜手术,定位成功率95.28%(95%CI 91.25%-99.32%),达到预设客观性能标准91%,中位定位时间3.1分钟,未观察到定位相关并发症。

要点

  • AR导航引导肺结节定位系统定位成功率达95.28%,超过预设91%的性能标准
  • 中位定位时间仅3.1分钟,中位结节距定位器距离5毫米
  • 104例(98.11%)软件识别与后处理流畅性及提示准确性评价为优秀

核心结论

  • 新型增强现实导航引导肺结节定位系统可有效且安全地辅助亚厘米肺结节定位。

研究设计与样本

  • 前瞻性、多中心、单臂、客观性能标准临床试验,共纳入106例接受肺结节定位及电视辅助胸腔镜切除术的患者。

主要发现

  • 101例定位成功,成功率95.28%(95%CI 91.25%-99.32%),达到客观性能标准91%。
  • 中位定位时间3.1分钟(范围1.0-22.0分钟),中位结节距定位器距离5毫米(范围1-9毫米)。
  • 104例(98.11%)软件识别、后处理软件流畅性及提示准确性评价为优秀。
  • 未观察到定位相关并发症。

关键数值与推荐

  • 主要终点定位成功率95.28%(95%CI 91.25%-99.32%),预设客观性能标准为91%。
  • 中位定位时间3.1分钟(范围1.0-22.0分钟),中位结节距定位器距离5毫米(范围1-9毫米)。

临床怎么用

  • 该系统可用于术前亚厘米肺结节定位,定位时间短、成功率较高,且未报告定位相关并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: With the popularization and wide acceptance of low-dose computed tomography lung cancer screening, an increasing number of lung cancers are found in the form of small pulmonary nodules (SPNs). Accurate, rapid, and safe localization of SPNs is crucial for their surgical resection. This study aims to evaluate the efficacy and safety of an augmented reality (AR) navigation-guided pulmonary nodule (PN) localization system. METHODS: This is a prospective, multicentre, single-arm objective performance criteria clinical trial. The puncture navigation software and PN localization system were employed in the operating room for preoperative localization of SPNs, and subsequent resection was performed by video-assisted thoracic surgery (VATS). The primary end point was the localization success, and the secondary end points included localization time, distance from nodule to localizer, device performance evaluation, and localization-related complication as a safety end point. RESULTS: A total of 106 patients underwent PN localization and VATS resection. Localization success was achieved in 101 patients at a rate of 95.28% (95% CI (confidence interval), 91.25%-99.32%), reaching the objective performance criteria of 91%. The median localization time was 3.1 min (range: 1.0-22.0 min). The median distance from nodule to localizer was 5 mm (range: 1-9 mm). In 104 (98.11%) patients, software recognition, post-processing software fluency, and post-processing software prompt accuracy were excellent. No localization-related complication was observed. CONCLUSIONS: The newly developed AR navigation-guided PN localization system is effective and safe in facilitating the localization of SPNs. CLINICAL REGISTRATION NUMBER: This study was registered with the Chinese Clinical Trial Registry (ChiCTR2200055612).

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Mei J, Liu Z, Wu Q, et al. A Prospective, Multicenter, Single-Arm Study to Evaluate the Efficacy and Safety of Augmented Reality Navigation-Guided Pulmonary Nodule Localization System. Eur J Cardiothorac Surg. 2026. PMID: 41581132. doi:10.1093/ejcts/ezag049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。